デフォルト表紙
市場調査レポート
商品コード
1362893

北米と欧州のeヘルス市場規模、シェア、動向分析レポート:製品別、サービス別、最終用途別、地域別、セグメント別予測、2023年~2030年

North America And Europe eHealth Market Size, Share & Trends Analysis Report By Product (Health Information Systems (HIS), Telemedicine), By Services (Monitoring, Diagnostics), By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
北米と欧州のeヘルス市場規模、シェア、動向分析レポート:製品別、サービス別、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年09月05日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米と欧州のeヘルス市場の成長と動向:

Grand View Research, Inc.の新しいレポートによると、北米と欧州のeヘルス市場規模は2030年までに4億310万米ドルに達すると予測されています。

同市場は、2023年から2030年にかけてCAGR 11.2%で拡大すると予測されています。同市場は主に、eヘルスソリューションを開発・展開する政府イニシアチブの増加、医療管理の一元化と合理化に対する需要の高まり、技術的に高度なeヘルスサービスの登場によって牽引されています。さらに、電子カルテ(EHR)システムは、副作用の追跡や疫学調査の支援に役立つため、市場のさらなる牽引役となることが期待されています。

COVID-19パンデミックと闘うために、現在のヘルスケア・システムを支援するために、政府や地域団体によって数多くの取り組みが開始されています。eヘルスは、医師が治療の時点で効果的な選択をするのに役立つため、パンデミック時にダイナミックな役割を果たしています。従って、市場プレーヤーはこの機会を利用して問題に対処し、最前線の医師にサポートを提供しています。

北米は、技術的に進んだ人口基盤の存在と、同地域で進行中の様々な活動により、2022年に最大の市場に浮上しました。前述の要因が市場拡大を後押しすると予想されます。ハイテク・ヘルスケア・インフラや高速インターネットが利用可能であることも、同地域の急拡大に寄与しています。その結果、認知度の向上が市場成長に大きな影響を与えると予測されます。

2021年に発表された報告書によると、米国では現在約50の医療拠点がこのようなeヘルス・プラットフォームを導入しており、遠隔医療を利用して外来患者の自宅を訪問しています。こうした遠隔医療やeヘルス技術は、COVID-19の世界の管理にとって極めて重要です。米国FDAによると、同国のヘルスケア消費者の少なくとも54%が、医療障害の治療、管理、モニタリングのために、FDAが承認したアプリやその他のオンラインツールを使用しています。

深刻な健康シナリオでは、意思決定支援は極めて重要です。さらに、これらのシステムは患者の医療記録を分析し、実行可能な選択肢のリストを提示し、そこから最も適切なものを選択します。市場の成長見通しは、プラットフォーム間のシステムの容易な互換性と相互運用性によって後押しされています。予測期間中、学者とソフトウェア開発者が協力して医療知識をユーザーに提供することで、大きな収入につながると期待されます。

さらに、COVID-19パンデミックの結果として、多くの新規企業が市場に参入しており、米国での市場成長を高めると予想されています。例えば、Cerner Corporationは2020年に、同社のCommunity Worksの顧客にVideo Visitプログラムと呼ばれる新しいビデオケアプラットフォームを提供すると述べています。

北米と欧州のeヘルス市場レポート・ハイライト

  • 製品別では、医療情報システム(HIS)が2022年に35.0%を超える最大の売上シェアを占めました。これは、医療業界におけるITシステムの開発・展開に向けた政府の取り組みや医療IT投資の増加によるものです。これにより、ヘルスケア情報システムの導入が増加しています。
  • モニタリングサービス分野は、臨床医や患者によるモニタリング機器の急速な導入により、今後数年間で顕著な成長を遂げる見通しです。
  • 最終用途に基づくと、プロバイダーが2022年に最大の収益シェアを占めました。在宅eヘルス・ソフトウェアの導入は、こうした患者により持続可能な治療を提供するための1つの方法です。
  • 遠隔医療製品セグメントは、遠隔医療の技術サポートと相互運用性のための斬新なイノベーションにより、予測期間中に有利な成長が見込まれます。
  • 市場競合他社は、新製品発売、製品革新、買収、提携などの戦略的イニシアチブをとり、互いに競争優位に立とうとしています。
  • 例えば、2021年9月、Apple Inc.は全体的な健康パラメータを設定したwatchOS 8の発売を発表しました。これには、ワークアウトの種類の更新、サイクリングモニター、マインドフルネス瞑想アプリなどの新機能があっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米と欧州のeヘルス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 北米および欧州のeヘルス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 北米と欧州のeヘルス:製品の推定・動向分析

  • 北米と欧州のeヘルス市場:重要なポイント
  • 北米と欧州のeヘルス市場:動向と市場シェア分析、2022年と2030年
  • ヘルス向けビッグデータ
  • 電子健康記録(EHR)
  • 医療情報システム
  • mヘルス
  • 遠隔医療

第5章 北米と欧州のeヘルス:サービスの推定・動向分析

  • 北米と欧州のeヘルス市場:重要なポイント
  • 北米と欧州のeヘルス市場:動向と市場シェア分析、2022年と2030年
  • 監視
  • 診断
  • ヘルスケアの強化
  • その他

第6章 北米と欧州のeヘルス:最終使用推定・動向分析

  • 北米と欧州のeヘルス市場:重要なポイント
  • 北米と欧州のeヘルス市場:動向と市場シェア分析、2022年と2030年
  • プロバイダー
  • 保険会社
  • ヘルスケア消費者

第7章 北米と欧州のeヘルス市場:地域推定・動向分析

  • 地域別の展望
  • 北米と欧州の地域別eヘルス市場:主要なマーケットプレースのポイント
  • 北米
  • 欧州

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Allscripts Healthcare, LLC
    • Epic Systems Corporation
    • Chronolife
    • Koninklijke Philips N.V.
    • Apple Inc.
    • Whoop
    • Silvertree
    • Healthwatch Telediagnostics Private Limited
    • Athos
    • IBM Corporation
    • Medtronic
    • Siemens Healthcare GmBH
    • Hexoskin
    • Emglare Inc.
    • Bioserenity
    • GetenFlux
    • Sensoria
    • Polar Electro
    • Movesense
    • Myontec
    • Myzone
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 4 North America eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America eHealth market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 8 U.S. eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 11 Canada eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 14 Europe eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe eHealth market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 18 Europe eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 21 UK eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 23 France eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 24 France eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 27 Italy eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 30 Spain eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 33 Sweden eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 36 Norway eHealth market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark eHealth market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark eHealth market, by service, 2018 - 2030 (USD Million)
  • Table 39 Denmark eHealth market, by end-use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Microneedle drug delivery systems: Market outlook

Fig. 9 Microneedle drug delivery systems: Competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 North America and Europe eHealth market driver impact

Fig. 15 North America and Europe eHealth market restraint impact

Fig. 16 North America and Europe eHealth market strategic initiatives analysis

Fig. 17 North America and Europe eHealth market: Product movement analysis

Fig. 18 North America and Europe eHealth market: Product outlook and key takeaways

Fig. 19 Big data for health market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 Electronic health record (EHR) market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 Health information system (HIS) market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 mHealth market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 Telemedicine market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 24 North America and Europe eHealth market: Services movement analysis

Fig. 25 North America and Europe eHealth market: Services outlook and key takeaways

Fig. 26 Monitoring market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 27 Vital signs market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Wristwear market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 29 Bodywear (garments) market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 31 Specialty market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Adherence monitoring market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 34 Sensors market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 36 Diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 Healthcare strengthening market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 39 North America and Europe eHealth market: End-use movement analysis

Fig. 40 North America and Europe eHealth market: End-use outlook and key takeaways

Fig. 41 Providers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 42 Insurers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 43 Healthcare consumers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 44 North America and Europe eHealth market: Regional movement analysis

Fig. 45 North America and Europe eHealth market: Regional outlook and key takeaways

Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 49 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

目次
Product Code: GVR-4-68039-950-3

North America And Europe eHealth Market Growth & Trends:

The North America and Europe eHealth market size is expected to reach USD 403.1 million by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 11.2% from 2023 to 2030. The market is primarily driven by an increasing number of government initiatives to develop and deploy eHealth solutions, rising demand for centralization and streamlining of healthcare administration, and the advent of technologically advanced eHealth services. Furthermore, Electronic Health Record (EHR) systems benefit in tracking adverse drug events as well as aid in epidemiology studies, which is further expected to drive the market.

To combat the COVID-19 pandemic, numerous initiatives are being started by government and community organizations to support the present healthcare system. It includes front-line clinics by state management, a volunteer panel of doctors, and numerous remote telemedicine applications. eHealth plays a dynamic role during the pandemic as it is helping doctors make effective choices at the point of care. Thus, market players are exploiting this opportunity to address the problem and offer support to forefront doctors.

North America emerged as the largest market in 2022 due to the presence of a technologically advanced population base and various ongoing activities in the region. The aforementioned factors are expected to boost market expansion. The availability of high-tech healthcare infrastructure as well as high-speed internet can be attributed to the region's rapid expansion. As a result, improved awareness is projected to have a major impact on market growth.

According to a report published in 2021, around 50 medical hubs in the U.S. currently have such eHealth platforms and are using telemedicine to visit outpatients at home. These telemedicine and eHealth technologies are crucial for COVID-19 global management. According to the U.S. FDA, at least 54% of healthcare consumers in the country use FDA-approved apps and other online tools for the treatment, management, and monitoring of medical disorders.

In a severe health scenario, decision support is crucial. Furthermore, these systems analyze patient medical records and present a list of viable options from which to choose the most appropriate. The market's growth prospects have been boosted by the easy compatibility and interoperability of systems across platforms. Over the projection period, academics and software developers are expected to collaborate to make medical knowledge available to users, resulting in significant income-generating.

Furthermore, as a result of the COVID-19 pandemic, many new companies are entering the market, which is expected to enhance the market growth in the U.S. For instance, Cerner Corporation stated in 2020 that it will be offering its Community Works clients a new video care platform called the Video Visit program.

North America And Europe eHealth Market Report Highlights:

  • By product, health information systems (HIS) accounted for the largest revenue share of over 35.0% in 2022 owing to an increase in government initiatives and healthcare IT investments to develop and deploy IT systems in the healthcare industry. This is increasing the adoption of healthcare information systems
  • The monitoring services segment is poised to witness noteworthy growth over the coming years due to the rapid adoption of monitoring devices by clinicians and patients
  • Based on end-use, providers held the largest revenue share in 2022. Implementing home-based eHealth software is one method for providing more sustainable treatment for these patients
  • The telemedicine product segment is expected to witness lucrative growth over the forecast period owing to novel innovations for technical support and interoperability of telemedicine
  • Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other
  • For instance, in September 2021, Apple Inc. announced the launch of watchOS 8, which has overall health parameters configured. This had new features such as updated workout types, cycling monitors, and a mindfulness meditation app

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Service
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Service outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe eHealth Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. North America and Europe eHealth Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. North America and Europe eHealth: Product Estimates & Trend Analysis

  • 4.1. North America and Europe eHealth Market: Key Takeaways
  • 4.2. North America and Europe eHealth Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Big Data for Health
    • 4.3.1. Big data for health market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Electronic Health Recorder (EHR)
    • 4.4.1. Electronic health recorder market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Health Information Systems
    • 4.5.1. Health Information Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. mHealth
    • 4.6.1. mHealth market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Telemedicine
    • 4.7.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America and Europe eHealth: Service Estimates & Trend Analysis

  • 5.1. North America and Europe eHealth Market: Key Takeaways
  • 5.2. North America and Europe eHealth Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Monitoring
    • 5.3.1. Monitoring market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Vital signs
      • 5.3.2.1. Vital signs market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.2. Wristwear
      • 5.3.2.2.1. Wristwear market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.3. Bodygear (garments)
      • 5.3.2.3.1. Bodywear (garments) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.4. Others
      • 5.3.2.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Specialty
      • 5.3.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.4. Adherence monitoring
      • 5.3.4.1. Adherence monitoring market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.5. Accessories
      • 5.3.5.1. Accessories monitoring market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.5.2. Sensors
      • 5.3.5.2.1. Sensors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.5.3. Other
      • 5.3.5.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic
    • 5.4.1. Diagnostic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Healthcare Strengthening
    • 5.5.1. Healthcare strengthening market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Other
    • 5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America and Europe eHealth: End-use Estimates & Trend Analysis

  • 6.1. North America and Europe eHealth Market: Key Takeaways
  • 6.2. North America and Europe eHealth Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Providers
    • 6.3.1. Providers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Insurers
    • 6.4.1. Insurers delivery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Healthcare Consumers
    • 6.5.1. Healthcare Consumers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America and Europe eHealth Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. North America and Europe eHealth Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Allscripts Healthcare, LLC
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Epic Systems Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Chronolife
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Koninklijke Philips N.V.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Apple Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Whoop
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Silvertree
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Healthwatch Telediagnostics Private Limited
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Athos
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. IBM Corporation
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Medtronic
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Siemens Healthcare GmBH
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Hexoskin
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Emglare Inc.
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Bioserenity
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. GetenFlux
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. Sensoria
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. Polar Electro
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives
    • 8.2.19. Movesense
      • 8.2.19.1. Company overview
      • 8.2.19.2. Financial performance
      • 8.2.19.3. Product benchmarking
      • 8.2.19.4. Strategic initiatives
    • 8.2.20. Myontec
      • 8.2.20.1. Company overview
      • 8.2.20.2. Financial performance
      • 8.2.20.3. Product benchmarking
      • 8.2.20.4. Strategic initiatives
    • 8.2.21. Myzone
      • 8.2.21.1. Company overview
      • 8.2.21.2. Financial performance
      • 8.2.21.3. Product benchmarking
      • 8.2.21.4. Strategic initiatives